Tag: TCT 2023

LIFE-BTK: Improving durability with bioresorbable technology

Speaking at TCT 2023 (23–26 October, San Francisco), vascular surgeon Ramon Varcoe (Sydney, Australia) reflects on the wider impact of the results of the...

LIFE-BTK: ‘We have had a number of failed trials below the...

Vascular surgeon Peter Schneider (San Francisco, USA) gives some context to results from the LIFE-BTK trial after they were presented at TCT 2023 (23–26...

TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough...

Results of the LIFE-BTK randomised controlled trial have just been presented at TCT 2023 (23–26 October, San Francisco, USA). The data show that, in...
patient-level

TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...

Data from a patient-level meta-analysis—a factor in the US Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices...